Wei-Wei DENG | Biological Sciences | Best Researcher Award

Posted on by Research Awards

Prof Dr. Wei-Wei DENG | Biological Sciences | Best Researcher Award

Prof Dr. Wei-Wei DENG, Anhui Agricultural University, China

Prof. Dr. Wei-Wei Deng is a leading expert in plant molecular biology and tea science at Anhui Agricultural University, China. With a Ph.D. from Ochanomizu University, Japan, her research focuses on the biosynthesis of secondary metabolites in tea plants, including caffeine, catechins, and theanine. She has published extensively in high-impact journals and received several prestigious awards, such as the Anhui Provincial Natural Science Award. As Vice Dean and doctoral supervisor, Prof. Deng has significantly advanced molecular understanding and industrial applications in tea science, making her a prominent figure in the global plant biology community.

Author Profile

Scopus

đŸ‘©â€đŸŽ“ Early Academic Pursuits: A Strong Foundation in Tea Science

Prof. Dr. Wei-Wei Deng’s academic journey reflects her unwavering passion for plant sciences, particularly in the specialized domain of tea plant biology. She began her academic career at Anhui Agricultural University, earning her Bachelor’s and Master’s degrees in Tea Science, where she cultivated a strong interest in the biochemistry and molecular mechanisms behind tea plant traits.

Her academic trajectory took an international turn when she pursued a Ph.D. in Life Sciences from the renowned Ochanomizu University in Japan. There, her doctoral research focused on the “Biosynthesis of Secondary Metabolites in Tea Plants,” laying a molecular foundation for what would become her lifelong research theme. This cross-cultural academic training equipped her with advanced tools in molecular biology, omics technologies, and a deeper insight into the functional genomics of plants.

đŸ‘©â€đŸ”Ź Professional Endeavors: Educator, Innovator, and Academic Leader

Currently serving as Vice Dean at the College of Tea Science, Anhui Agricultural University, Prof. Deng is also affiliated with the National Key Laboratory for Tea Plant Germplasm Innovation and Resource Utilization. Her leadership extends beyond administration to mentoring doctoral students and guiding interdisciplinary research teams.

As an academic leader, she contributes to shaping national agendas in tea science and represents a new generation of researchers actively involved in transforming traditional agricultural research into modern, molecular-driven innovations.

🔬 Contributions and Research Focus: Unlocking the Molecular Secrets of Tea 🍃

Prof. Deng’s research spans across several cutting-edge areas of plant molecular biology, with a keen focus on tea plant metabolism. Her primary contributions include:

  • Secondary Metabolite Biosynthesis: Prof. Deng has deciphered the biosynthetic pathways of key tea compounds like caffeine, catechins, and theanine. This has improved the understanding of aroma and flavor formation, enabling targeted breeding and quality control.

  • Functional Genomics of Albino Tea: She has led molecular investigations into albino tea leaf mutants, analyzing gene expressions and metabolite profiles to understand leaf discoloration, temperature responses, and biochemical advantages.

  • Integration of Omics Technologies: By combining metabolomics, transcriptomics, and proteomics, her team has mapped complex metabolic responses under varying environmental and genetic conditions.

  • Microbial Interactions and Endophytes: Her work has expanded into how endophytic bacteria influence tea plant growth and metabolite production, adding a new layer of biological complexity and practical application.

Her numerous papers in international journals such as Journal of Agricultural and Food Chemistry, Food Chemistry, International Journal of Molecular Sciences, and Food Research International have garnered recognition for their depth and scientific rigor.

🏆 Accolades and Recognition: Celebrating Excellence

Prof. Deng’s excellence has been consistently acknowledged through prestigious honors and awards, including:

  • đŸ„‡ First Prize, Anhui Provincial Natural Science Award

  • 🌟 Distinguished Young Scholar, Anhui Science Foundation

  • đŸŒ± Rising Star in Education and University Teaching Celebrity, Anhui Province

  • đŸ§Ș Young Talent Award from the China Tea Science Society

  • 🧬 Multiple competitive research grants from the National Natural Science Foundation of China

These accolades highlight both her academic merit and societal relevance, acknowledging her as a key contributor to scientific innovation in tea biotechnology.

🌍 Impact and Influence: From Lab to Leaf to Society

Prof. Deng’s influence extends beyond academia into the agricultural industry and regional policy development. She has been a major force behind:

  • Developing standardized tea processing technologies

  • Supporting local economic development through scientific advisory roles

  • Strengthening industry-academia collaborations that transform scientific discoveries into practical innovations for farmers and tea enterprises

As a respected doctoral supervisor, she has mentored the next generation of plant scientists, emphasizing innovation, integrity, and sustainable development.

🧬 Legacy and Future Contributions: Paving the Way for Molecular Tea Science

Prof. Deng is building a legacy rooted in translational plant biology—transforming complex molecular findings into field applications that benefit farmers, processors, and consumers. Looking forward, her research is expected to delve deeper into:

  • Epigenetics and environmental responses in tea plants

  • Expanding the understanding of plant-microbe interactions

  • Innovations in precision agriculture and tea quality monitoring

Her work will continue to shape how tea is cultivated, processed, and consumed—enhancing both nutritional value and economic sustainability.

✍Publication Top Notes

📘 Metabolomics and sensory evaluation reveal the influence of four albino tea cultivars on the quality of processed green tea

Author: Yifan Li, Zhen Han, Miao Wang, Yaxing Yan, Ruihong Ma, Hongping Wang, Wei-Wei Deng

Journal: Food Research International

Year: 2025

📘Investigation of the effect of over-fired drying on the taste and aroma of Lu’an Guapian tea using metabolomics and sensory histology techniques

Author: Jixin Zhang , Wanzhen Feng , Zhichao Xiong , Shuai Dong , Caiyan Sheng , Yida Wu , Guojian Deng , Wei-Wei Deng , Jingming Ning

Journal: Food Chemistry

Year: 2024

 

Soumitra Moulick | Microbiology | Best Researcher Award | 13395

Posted on by Research Awards

Mr. Soumitra Moulick | Microbiology | Best Researcher Award

Mr. Soumitra Moulick, TCG Lifesciences Pvt. Ltd., India

Mr. Soumitra Moulick, Lead Scientist at TCG Lifesciences Pvt. Ltd., brings over 18 years of expertise in drug discovery research, with impactful contributions in antimicrobial, anti-inflammatory, and anticancer therapeutics. Currently pursuing a PhD at NIT Raipur, he has published peer-reviewed papers and is engaged in an ICMR-funded project on antibiotic-resistant E. coli. His work has supported over 15 global collaborations with pharmaceutical leaders, earning recognition including a best poster award at IIIT Allahabad. His consistent commitment to innovation and translational science underscores his suitability for the Best Researcher Award.

Profile

Scopus

🎓 Early Academic Pursuits

Mr. Soumitra Moulick embarked on his academic journey with a Master’s degree from a reputed Indian university, laying a strong foundation in life sciences and pharmacological research. From the beginning, his keen interest in drug discovery and therapeutic development drove him to pursue in-depth studies in microbiology, pharmacology, and biochemistry. His academic dedication was further demonstrated when he enrolled in a PhD program at the prestigious National Institute of Technology (NIT), Raipur, where he continues to explore advanced research in antibacterial drug discovery. His early education equipped him with a robust scientific mindset and set the stage for a dynamic career in the pharmaceutical sector.

đŸ§Ș Professional Endeavors

Mr. Moulick has devoted over 18 years of his professional life to TCG Lifesciences Pvt. Ltd., Kolkata, one of India’s leading Contract Research Organizations (CROs). Rising through the ranks, he currently serves as a Lead Scientist in the In-vitro Pharmacology Department. In this role, he has led and collaborated on more than 15 drug discovery projects, targeting diseases in the therapeutic areas of oncology, infectious diseases, and inflammation.

His work spans protocol development, in-vitro screening, target validation, and assay optimization. Mr. Moulick has worked closely with world-renowned pharmaceutical companies such as Pfizer, Roche, Takeda, Grunenthal, MMV, and DNDi, showcasing his ability to integrate scientific rigor with industry demands. His career at TCG Lifesciences stands as a testament to his commitment, technical excellence, and leadership in translational research.

🔬 Contributions and Research Focus

Mr. Moulick’s primary research interests lie in antimicrobial resistance (AMR), anti-inflammatory therapeutics, and oncology drug discovery. His doctoral research focuses on antibiotic-resistant Escherichia coli, a major causative agent of urinary tract infections. This work is supported by the Indian Council of Medical Research (ICMR) under Grant No. DDR/IIRP23/0569.

He has already published two peer-reviewed research articles in reputed journals such as Microbial Drug Resistance and Microbial Pathogenesis. Despite the limitations on publishing often faced in CRO environments, Mr. Moulick has successfully balanced industry confidentiality with academic contribution. His scientific research emphasizes innovation, with a focus on identifying novel molecular targets, validating high-throughput screening methodologies, and exploring natural and synthetic compound libraries for drug efficacy.

🏅 Accolades and Recognition

Mr. Moulick’s contributions have not gone unnoticed. His poster presentation at the International Webinar cum Workshop on Recent Developments in Applied Biotechnology (organized by IIIT Allahabad) was honored with a Best Poster Award, reflecting the academic community’s recognition of his impactful research.

One of his recent publications received a provisional selection for the “Best Researcher Award”, further validating the significance and originality of his scientific output. In addition to this, he is currently in the process of contributing a book chapter, and he has one patent under review, indicating his continued engagement in knowledge creation and technology transfer.

🌍 Impact and Influence

Over nearly two decades, Mr. Moulick has significantly influenced both industry and academic research through his extensive project experience and collaborative spirit. His ability to work with global pharmaceutical giants has not only enhanced the credibility of Indian CROs but also brought innovative therapeutic candidates closer to clinical application.

His research on antibiotic resistance has real-world implications, particularly in the context of rising multidrug-resistant infections. By identifying alternative treatment strategies and molecular targets, Mr. Moulick’s work contributes meaningfully to public health and global medicine. His influence extends across laboratories, boardrooms, and academic institutions, as he frequently engages in collaborative projects that bridge academia and industry.

🌟 Legacy and Future Contributions

Looking ahead, Mr. Moulick is poised to further strengthen his contributions to drug discovery and biomedical innovation. His future endeavors include completing his PhD with a high-impact third publication, finalizing his patent application, and authoring a comprehensive book chapter that can serve as a resource for young researchers and professionals.

He aims to mentor early-career scientists in preclinical research and build a legacy of scientific excellence, collaboration, and integrity. With a vision to drive innovative, affordable, and accessible therapeutics, Mr. Moulick is committed to being a catalyst for change in the Indian and global pharmaceutical landscape.

His unique blend of academic rigor, industrial experience, and collaborative mindset makes him a valuable contributor to the scientific community, and his nomination for the Best Researcher Award is both timely and well-deserved.

Publication Top Notes

Bactericidal action of ginger (Zingiber officinale Roscoe) extract against Escherichia coli through synergistic modulation of the AcrAB-TolC efflux pump and inhibition of peptidoglycan synthesis: In vitro and in silico approaches

Author: S., Moulick, Soumitra, D.N., Roy, Dijendra Nath

Journal: Microbial Pathogenesis

Year: 2025

Bioflavonoid Baicalein Modulates Tetracycline Resistance by Inhibiting Efflux Pump in Staphylococcus aureus

Author: Soumitra Moulick and Dijendra Nath Roy

Journal: Microbial Drug Resistance

Year: 2024

Obey Zveushe | Applied microbiology | Best Researcher Award | 13171

Posted on by Research Awards

Dr. Obey Zveushe | Applied microbiology | Best Researcher Award

Dr. Obey Zveushe, Southwest University of Science and Technology, China

Dr. Obey Zveushe is a distinguished academic and researcher affiliated with Southwest University of Science and Technology in China. His expertise lies in [insert specific areas of expertise], contributing significantly to advancements in his field through teaching, research, and innovation. Dr. Zveushe is dedicated to fostering knowledge and collaboration within the global academic community.

Profile

Google scholar

Early Academic Pursuits đŸŒ±

Dr. Zveushe Obey Kudakwashe’s academic journey reflects a deep passion for scientific exploration and an unwavering commitment to excellence. After completing his early education, he embarked on a path of advanced studies that culminated in a Ph.D. from Southwest University of Science and Technology, China. His doctoral research laid a strong foundation for his specialization in plant-microbe interactions, focusing on microbial ecology and plant physiology. This phase of his career marked the beginning of a lifelong dedication to understanding and addressing critical environmental and agricultural challenges.

Professional Endeavors 🧑‍🔬

Currently serving as a postdoctoral researcher at Southwest University of Science and Technology, Dr. Zveushe has built an impressive portfolio of work that combines rigorous scientific inquiry with practical applications. His professional engagements span several high-impact research projects, including sustainable soybean production and the remediation of cadmium and chromium in soils. With five consultancy projects under his belt, he has also bridged the gap between academia and industry, providing valuable insights to enhance sustainable agricultural practices.

Contributions and Research Focus đŸŒŸ

Dr. Zveushe’s research contributions are both groundbreaking and transformative. His work emphasizes the integration of microbial inoculation techniques to improve agricultural productivity and environmental health. Among his most notable achievements is the co-inoculation of Saccharomyces spp. with Bradyrhizobium japonicum, which has significantly advanced atmospheric nitrogen fixation in soybeans, enhancing crop yields and soil fertility.

Additionally, his studies on arbuscular mycorrhizal fungi have unveiled innovative strategies for cadmium detoxification in perennial ryegrass, a critical step in addressing soil contamination. His broader research areas include environmental remediation, microbial ecology, soil fertility, and bioresource transformation, all of which align with global sustainability goals.

Accolades and Recognition 🏆

Dr. Zveushe’s dedication to research excellence is evident in his eight publications in prestigious journals indexed by SCI and Scopus. These contributions have garnered citations that reflect his impact on the scientific community, with an i5-index underscoring the significance of his work. Although he has not yet pursued patents or authored books, his work continues to inspire and influence peers in the field.

Impact and Influence 🌍

The practical implications of Dr. Zveushe’s research extend far beyond the academic realm. His innovative techniques for sustainable agriculture and soil remediation have the potential to transform farming practices, particularly in regions grappling with soil degradation and food insecurity. By reducing reliance on chemical fertilizers and promoting natural solutions, his work fosters environmental resilience and supports global efforts to combat climate change.

Legacy and Future Contributions ✹

Dr. Zveushe’s journey is far from over. As a forward-thinking researcher, he envisions a future where his work continues to shape sustainable agricultural practices and environmental conservation strategies. By mentoring emerging scientists and collaborating on interdisciplinary projects, he aims to leave a lasting legacy that will influence generations to come. His unwavering dedication to innovation, combined with his commitment to addressing real-world challenges, positions him as a leader in his field.

Publication Top Notes

Unraveling the effects of arbuscular mycorrhizal fungi on cadmium uptake and detoxification mechanisms in perennial ryegrass (Lolium perenne)

Author: Y Han, OK Zveushe, F Dong, Q Ling, Y Chen, S Sajid, L Zhou, VR de Dios
Journal: Science of The Total Environment
Year: 2021
Author: S Sajid, OK Zveushe, VR de Dios, F Nabi, YK Lee, AR Kaleri, L Ma, …
Journal: Bioresource Technology
Year: 2022

Hydraulic and photosynthetic limitations prevail over root non‐structural carbohydrate reserves as drivers of resprouting in two Mediterranean oaks

Author: V Resco de Dios, C Arteaga, JJ Peguero‐Pina, D Sancho‐Knapik, H Qin, …
Journal: Plant, Cell & Environment
Year: 2020

Effects of Co-Inoculating Saccharomyces spp. with Bradyrhizobium japonicum on Atmospheric Nitrogen Fixation in Soybeans (Glycine max (L.))

Author: OK Zveushe, VR de Dios, H Zhang, F Zeng, S Liu, S Shen, Q Kang, …
Journal: Plants
Year: 2023

Aroop Mohanty | Microbiology | Best Researcher Award

Posted on by Research Awards

Dr. Aroop Mohanty | Microbiology | Best Researcher Award

Associate Professor at AIIMS Gorakhpur, India.

Dr. Aroop Mohanty is an accomplished professional with a robust background in microbiology and infectious diseases. Currently serving as an Assistant Professor at AIIMS Gorakhpur, he holds extensive experience in teaching, clinical practice, and research. Dr. Mohanty completed his M.D. in Microbiology from SMIMS, Sikkim, and a Postgraduate Diploma in Infectious Diseases from the University of New South Wales. His research interests encompass innovative diagnostic methods, antimicrobial resistance, hospital-acquired infections, and microbiome studies. Dr. Mohanty has received recognition for his contributions, including awards for teaching excellence, research innovation, and leadership in antimicrobial stewardship. His commitment to advancing healthcare through rigorous research and education underscores his role as a leading figure in the field of microbiology.

Professional Profiles:

Education

Dr. Aroop Mohanty has pursued a rigorous academic journey, beginning with his schooling at K.V No: 1 in Ferozepur Cantt, Punjab, where he achieved an impressive 86.6% in his 10th grade examinations under the CBSE board in 2000. Continuing his academic excellence, he completed his 12th grade at K.V No: 2 in Bhubaneswar, Odisha, securing 77.2% in 2002. Dr. Mohanty then pursued his passion for medicine by obtaining his M.B.B.S degree with an internship from MCOMS, Pokhara, Nepal, affiliated with Kathmandu University, in 2010, with a notable first attempt success and a focus on comprehensive medical training. He further specialized in Microbiology, earning his M.D. from SMIMS, Gangtok, Sikkim, through Sikkim Manipal University in 2015, demonstrating his commitment to advanced medical knowledge. Driven by a quest for expertise in infectious diseases, he pursued and completed a Postgraduate Diploma in Infectious Diseases from the School of Public Health and Community Medicine at the University of New South Wales in 2018, further enriching his medical qualifications and global perspectives.

Professional Experience

Dr. Aroop Mohanty brings a wealth of experience in academic and clinical settings, currently serving as an Assistant Professor in the Department of Microbiology at AIIMS Gorakhpur since May 2020. Prior to this, he held the position of Assistant Professor at AIIMS Rishikesh from September 2019 to May 2020, where he contributed significantly to medical education and research. His earlier roles include Senior Resident at AIIMS Rishikesh from July 2016 to September 2019, where he gained extensive clinical experience and expertise in microbiology. Before joining AIIMS Rishikesh, Dr. Mohanty served as a Registrar at Kasturba Medical College Hospital in Mangalore from November 2015 to July 2016, where he further honed his skills in medical practice and patient care. Throughout his career, he has been actively involved in teaching undergraduate and paramedical students, conducting research, and contributing to hospital infection control measures and academic development.

Research Interest

Dr. Aroop Mohanty’s research interests encompass several key areas within microbiology and infectious diseases. He is particularly interested in investigating novel diagnostic methods for infectious pathogens, focusing on the development and evaluation of molecular and serological assays. His expertise extends to studying antimicrobial resistance patterns and mechanisms, aiming to contribute insights into combating emerging resistance trends through antimicrobial stewardship and innovative treatment strategies. Additionally, Dr. Mohanty is keen on exploring hospital-acquired infections and infection control measures, with a focus on improving surveillance techniques and implementing effective interventions to enhance patient safety. He is also interested in epidemiological studies of infectious diseases, including outbreak investigations and disease transmission dynamics, leveraging his clinical and academic background to inform public health strategies. Furthermore, Dr. Mohanty is passionate about the role of microbiota in health and disease, exploring the interactions between host microbiomes and infectious agents to advance understanding and therapeutic approaches in microbial ecology. His research aims to bridge the gap between basic science discoveries and clinical applications, ultimately contributing to advancements in infectious disease management and public health.

Award and Honors

Dr. Aroop Mohanty has garnered several prestigious awards and honors throughout his career, reflecting his outstanding contributions in the field of microbiology and infectious diseases. In 2023, he was awarded the “Outstanding Contribution in Microbiology Education” for his dedicated mentorship and exceptional teaching of medical students at AIIMS Gorakhpur, setting a benchmark in microbiology education. His research prowess earned him the “Research Excellence Award in Infectious Diseases” in 2022, recognizing his pioneering work in developing novel diagnostic methods and investigating antimicrobial resistance patterns. Dr. Mohanty was also honored with the “Best Poster Presentation at International Conference on Microbiology” in 2021 for his impactful research on hospital-acquired infections and infection control measures. His leadership in antimicrobial stewardship was acknowledged with the “Leadership in Antimicrobial Stewardship” award in 2018, highlighting his advocacy for responsible antimicrobial use and patient safety initiatives. Additionally, he received the “Gold Medal for Academic Excellence in MD Microbiology” in 2015 for achieving top academic performance during his MD studies at SMIMS, Sikkim Manipal University. Dr. Mohanty’s commitment to excellence in hospital infection control was recognized with the “Best Resident Award in Hospital Infection Control” in 2014, underscoring his dedication to ensuring high standards of patient care and safety.

Research Skills

Dr. Aroop Mohanty possesses comprehensive research skills honed through his extensive experience in microbiology and infectious diseases. He excels in identifying research questions and formulating hypotheses, drawing from his in-depth knowledge of pathogen biology and disease mechanisms. Dr. Mohanty is adept at conducting systematic literature reviews to explore existing research and identify gaps in knowledge, paving the way for innovative research directions. His expertise extends to designing and executing rigorous research methodologies, including both qualitative and quantitative approaches, such as molecular biology techniques, epidemiological studies, and clinical trials. He demonstrates proficiency in data collection and analysis, utilizing advanced statistical methods to interpret findings and draw meaningful conclusions. Dr. Mohanty is committed to ethical research practices, ensuring compliance with regulatory standards and contributing to the advancement of evidence-based practices in infectious disease management. His ability to effectively communicate research findings through publications and presentations underscores his role as a thought leader in microbiology research.

Publications

  1. Health problems in healthcare workers: A review
    • Authors: A Mohanty, A Kabi, AP Mohanty
    • Year: 2019
    • Citations: 166
    • Journal: Journal of family medicine and primary care 8 (8), 2568-2572
  2. Corona health‑care warriors in India: knowledge, attitude, and practices during COVID‑19 outbreak
    • Authors: YB Aroop Mohanty, Vanya Singh, Rajesh Kumar, Puneet Kumar Gupta
    • Year: 2021
    • Citations: 48
    • Journal: Journal of Education and Health Promotion 10, 1-9
  3. First Monkeypox deaths outside Africa: no room for complacency
    • Authors: R Sah, A Mohanty, A Abdelaal, A Reda, AJ Rodriguez-Morales
    • Year: 2022
    • Citations: 41
    • Journal: Therapeutic Advances in Infectious Disease 9, 20499361221124027
  4. Monkeypox viral detection in semen specimens of confirmed cases: a systematic review and meta‐analysis
    • Authors: A Reda, A Abdelaal, AM Brakat, BI Lashin, M Abouelkheir, B Abdelazeem
    • Year: 2023
    • Citations: 39
    • Journal: Journal of Medical Virology 95 (1), e28250
  5. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review
    • Authors: MA Shamim, BK Padhi, P Satapathy, SD Veeramachaneni, C Chatterjee
    • Year: 2023
    • Citations: 37
    • Journal: International Journal of Infectious Diseases 127, 150-161
  6. Effectiveness of Video-Based Online Training for Health Care Workers to Prevent COVID-19 Infection: An Experience at a Tertiary Care Level Institute, Uttarakhand, India
    • Authors: SR Rakesh sharma, Aroop Mohanty, Vanya Sharma, Puneet Kumar Gupta, Pratima Gupta
    • Year: 2021
    • Citations: 31
    • Journal: Cureus 13 (05), 01-11
  7. Monkeypox reported in India – South East Asia Region: Health and economic challenges
    • Authors: DK Sah R, Mohanty A, Siddiq A, Singh P, Abdelaal A, Alshahrani A
    • Year: 2022
    • Citations: 30
    • Journal: The Lancet Regional Health – Southeast Asia 4
  8. Public health emergency of international concern declared by the World Health Organization for monkeypox
    • Authors: R Sah, BK Padhi, A Siddiq, A Abdelaal, A Reda, B Ismail Lashin
    • Year: 2022
    • Citations: 27
    • Journal: Global Security: Health, Science and Policy 7 (1), 51-56
  9. Epidemiologic situation of HIV and Monkeypox Coinfection: A systematic review
    • Authors: B Ortiz-Saavedra, ES Montes-Madariaga, C Cabanillas-Ramirez, N Alva
    • Year: 2023
    • Citations: 25
    • Journal: Vaccines 11 (2), 246
  10. Potentially asymptomatic infection of monkeypox virus: a systematic review and meta-analysis
    • Authors: P Satapathy, P Mohanty, S Manna, MA Shamim, PP Rao, AK Aggarwal
    • Year: 2022
    • Citations: 24
    • Journal: Vaccines 10 (12), 2083

 

 

DEROSA LISA | Immunology and Microbiology | Best Researcher Award

Posted on by Research Awards

Assist Prof Dr. DEROSA LISA | Immunology and Microbiology | Best Researcher Award

MD, PhD at Gustave Roussy, France.

Associate Professor Dr. Lisa Derosa is a leading medical oncologist and researcher at Gustave Roussy Cancer Center (GRCC) in France, specializing in tumor immunology and cancer immunotherapy. With an MD from Pisa University and a PhD in Immunology from Paris-Sud University, she has significantly contributed to understanding the immunosuppressive role of antibiotics and the impact of gut microbiota on antitumor immunity. Since 2016, Dr. Derosa has pioneered research in these areas, earning numerous prestigious awards including the Conquer Cancer Foundation ASCO Merit Award and recognitions from ESMO and European Urology. She directs the ClinicoBiome Program at GRCC and co-directs the RHU Clinical Program Grant “Immunolife” and the EU Program Grant “Oncobiome.” Her research skills include clinical trial design, metagenomic analysis, immunological assays, and pharmacodynamic studies, making her a leader in microbiota-centered cancer therapies. Dr. Derosa’s collaborative approach and interdisciplinary projects have resulted in over 100 publications and significant advancements in cancer immunotherapy.

Professional Profiles:

Education

Associate Professor Dr. Lisa Derosa’s educational journey is marked by a series of prestigious degrees and certifications. In 2023, she became an Associate Professor of Immunology at Paris-Saclay University in France. Prior to that, in 2019, she earned her PhD in Immunology from Paris-Sud University and registered as a physician in France the same year. She also obtained a University Diploma in Animal Experimentation Level 1 from Sorbonne University, Paris, in 2018. Her earlier academic achievements include a DiplĂŽme Universitaire EuropĂ©en de Recherche Translationnelle Et Clinique en CancĂ©rologie (DUERTECC) from Paris-Sud University and a DiplĂŽme d’UniversitĂ© Carcinologie ClĂ­niques (DUC) from UniversitĂ© Paris XI, both in 2016. Dr. Derosa completed her M2 in Pharmacology, Clinical Trial in Oncology at Pisa University in Italy in 2015 and became Board Certified in Medical Oncology from the same university in 2014. She first qualified as a physician in Italy in 2009, following her MD from the School of Medicine at Pisa University in 2008.

Professional Experience

Associate Professor Dr. Lisa Derosa has a distinguished career in medical oncology and cancer immunology. Since 2022, she has been serving as the Co-Coordinator of the RHU IMMUNOLIFE (PIA2) multi-team program project in France and as a member of the Scientific Advisory Board for everImmune. In the same year, she was appointed as an Associate Professor of Immunology at Paris-Saclay University and a Senior Research Associate in the Cancer Immunology Department at Gustave Roussy Cancer Center (GRCC). Dr. Derosa has also been the Clinical Director of the ClinicoBiome Program at GRCC since 2020 and has held the position of Medical Oncology Specialist at GRCC since 2020. From 2017 to 2021, she co-coordinated the PIA2 RHU TORINO LUMIERE project. She has also been a Co-Coordinator of the H2020 ONCOBIOME project since 2019. Prior to these roles, Dr. Derosa served as a clinical attending in the Genitourinary and Lung Department at GRCC from 2019 to 2020 and completed a clinical fellowship in the Genitourinary Medical Oncology Department at GRCC from 2016 to 2019. Before joining GRCC, she was a clinical attending in the Oncology Department at Hospital S. Chiara-Pisa from 2014 to 2016. Additionally, she gained valuable experience as a visiting student at GRCC in 2013 and at the Oncology Department at Ospedali Riuniti di Livorno from 2006 to 2008.

Award and Honors

Associate Professor Dr. Lisa Derosa has received numerous prestigious awards and honors throughout her career, reflecting her significant contributions to oncology and immunology. In 2023, she was honored with the Conquer Cancer Foundation ASCO Merit Award. The previous year, she received an accolade from the European Society for Medical Oncology (ESMO) at their Asia Annual Meeting. In 2021, she was awarded the Best Scientific Paper published on Fundamental Research by European Urology and also received the ASCO Merit Award in Lung Cancer, supported by Frances A. Shepherd. Her exceptional work earned her the EATI Award in 2020. The year 2018 was particularly notable, as she received the Best Paper Award from ESMO YOC, the ESMO Annual Meeting Award, the Early Detection of Cancer Conference Award from ARC, and the Conquer Cancer Foundation ASCO Merit Award. In 2017, she was recognized with multiple Conquer Cancer Foundation ASCO Merit Awards, including the Genitourinary Cancer Merit Award. In 2016, she was the recipient of the 5th Pieter de Mulder Memorial Prize and the ESMO Translational Research Fellowship Award. Her early career was distinguished by the AIOM Award for young researchers in Oncology in 2015, the ESMO Annual Meeting Award in 2014, and the ITT Stage in Oncology Award from the Istituto Toscano Tumori in 2013.

Research Interest

Associate Professor Dr. Lisa Derosa’s research interests lie at the intersection of tumor immunology and cancer immunotherapy, with a particular focus on the immunosuppressive role of antibiotics in cancer treatment and the impact of gut microbiota on antitumor immunity. Since 2016, she has been pioneering research in these areas, exploring how the composition of gut microbiota can regulate the effectiveness of immune checkpoint inhibitors. Her innovative work has led to significant insights into the microbiota’s role in cancer treatment, making her a leading figure in the development of microbiota-centered interventions. Dr. Derosa currently directs the Microbiota-Centered Intervention Program (ClinicoBiome) at Gustave Roussy Cancer Center and co-directs the RHU Clinical Program Grant “Immunolife” as well as the EU Program Grant “Oncobiome.” Her research continues to bridge clinical oncology with translational research, aiming to improve patient outcomes through a deeper understanding of the immune system’s interactions with cancer therapies.

Research Skills

Associate Professor Dr. Lisa Derosa possesses a comprehensive skill set in the field of cancer immunology and immunotherapy, characterized by her expertise in clinical and translational research. She has extensive experience in designing and conducting clinical trials, particularly those investigating the interactions between gut microbiota and immune checkpoint inhibitors. Dr. Derosa is skilled in metagenomic analysis, allowing her to identify microbiome-based biomarkers that predict patient response to immunotherapy. Her proficiency in immunological assays and molecular biology techniques has been instrumental in her research on the immunosuppressive effects of antibiotics and the regulatory role of gut microbiota in antitumor immunity. Additionally, she has a strong background in pharmacodynamic and pharmacokinetic studies, which she has applied in various phase II clinical trials. Dr. Derosa’s ability to integrate clinical data with cutting-edge laboratory research has made her a leader in the development of microbiota-centered cancer therapies. Her collaborative projects often involve multidisciplinary teams, highlighting her skills in project management and scientific communication.